生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | Flavoxate Hydrochloride is a muscarinic AChR antagonist. It has been reported that flavoxate causes a concentration-dependent relaxation of the tension elicited by muscarinic stimulation (IC50=35 μM) or 5 mM extracellular Ca2+ (IC50=83 μM) in rat detrusor. And flavoxate caused a concentration-dependent relaxation of human urinary bladder precontracted by K+ with much higher potency (IC50=2 μM)[3]. Flavoxate (10-8-10-5 M) inhibited cAMP formation in a concentration-dependent manner. Flavoxate (3 mg/kg, i.v.) completely abolished rhythmic bladder contractions in vehicle-pretreated rats, but not in PTX-pretreated (pertussis toxin ) rats[4]. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00440739 | Pain | Phase 4 | Completed | - | Thailand ... 展开 >> Faculty of Medicine Siriraj Hospital, Mahidol University Bangkok, Thailand, 10700 收起 << |
NCT00992238 | Healthy | Phase 1 | Completed | - | United States, North Dakota ... 展开 >> PRACS Institute, Ltd Fargo, North Dakota, United States, 58104 收起 << |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.34mL 0.47mL 0.23mL |
11.68mL 2.34mL 1.17mL |
23.37mL 4.67mL 2.34mL |
参考文献 |
---|